Capital Asset Advisory Services LLC Sells 312 Shares of Colgate-Palmolive Company $CL

Capital Asset Advisory Services LLC lessened its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 1.3% in the second quarter, HoldingsChannel.com reports. The fund owned 23,206 shares of the company’s stock after selling 312 shares during the period. Capital Asset Advisory Services LLC’s holdings in Colgate-Palmolive were worth $2,136,000 at the end of the most recent reporting period.

A number of other large investors have also recently modified their holdings of the business. Price T Rowe Associates Inc. MD boosted its stake in Colgate-Palmolive by 18.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 34,009,078 shares of the company’s stock worth $3,186,651,000 after buying an additional 5,269,140 shares in the last quarter. Nuveen LLC purchased a new stake in shares of Colgate-Palmolive in the 1st quarter valued at $217,593,000. Goldman Sachs Group Inc. grew its holdings in shares of Colgate-Palmolive by 34.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 7,980,387 shares of the company’s stock valued at $747,762,000 after purchasing an additional 2,045,191 shares during the last quarter. Diamond Hill Capital Management Inc. grew its holdings in shares of Colgate-Palmolive by 45.0% during the 1st quarter. Diamond Hill Capital Management Inc. now owns 5,562,968 shares of the company’s stock valued at $521,250,000 after purchasing an additional 1,727,105 shares during the last quarter. Finally, GAMMA Investing LLC grew its holdings in shares of Colgate-Palmolive by 10,601.7% during the 1st quarter. GAMMA Investing LLC now owns 1,105,379 shares of the company’s stock valued at $103,574,000 after purchasing an additional 1,095,050 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Morgan Stanley reduced their target price on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating on the stock in a report on Monday, August 4th. UBS Group reduced their target price on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating on the stock in a report on Thursday, July 17th. Barclays increased their target price on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the company an “equal weight” rating in a report on Tuesday, July 15th. Citigroup reduced their target price on shares of Colgate-Palmolive from $108.00 to $105.00 and set a “buy” rating on the stock in a report on Monday, August 4th. Finally, Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $88.00 to $83.00 and set an “underweight” rating on the stock in a report on Monday, August 4th. Seven equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $98.00.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $83.35 on Friday. The firm has a market cap of $67.37 billion, a PE ratio of 23.41, a price-to-earnings-growth ratio of 4.37 and a beta of 0.35. Colgate-Palmolive Company has a 12-month low of $82.29 and a 12-month high of $106.26. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 6.79. The company’s fifty day simple moving average is $85.95 and its two-hundred day simple moving average is $89.54.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. The business had revenue of $5.11 billion for the quarter, compared to analyst estimates of $5.03 billion. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The company’s revenue was up 1.0% on a year-over-year basis. During the same quarter last year, the firm earned $0.91 EPS. As a group, equities analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 17th will be paid a dividend of $0.52 per share. The ex-dividend date of this dividend is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Colgate-Palmolive’s payout ratio is presently 58.43%.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.